Rapid correction of hyperkalemia reduces mortality by half

In a new study published in the American Journal of Emergency Medicine, Adam Singer, MD, et al reported that quickly correcting high potassium levels, a condition known as hyperkalemia, in emergency department patients cut mortality in that population by half.

In the study, Singer, professor and vice chair of research for the Department of Emergency Medicine in the Renaissance School of Medicine at Stony Brook University, and colleagues, reviewed nearly 115,000 Stony Brook University Hospital ED visits during 2016 and 2017, finding the mortality rate was significantly reduced in this patient cohort (6.3 % vs. 12.7 %).

Millions of patients suffering with diabetes, heart failure, hypertension and renal failure are at an increased risk for hyperkalemia. Many therapies to treat these conditions may also increase potassium levels.

Because of the increasing risk of hyperkalemia in this population, it is important, as our study showed, to develop protocols that help quickly identify and correct hyperkalemia while the patient is still in the emergency department."

Dr. Adam Singer, professor and vice chair of research for the Department of Emergency Medicine in the Renaissance School of Medicine at Stony Brook University

Source:
Journal reference:

Singer, A. J., et al. (2019) Rapid correction of hyperkalemia is associated with reduced mortality in ED patients. American Journal of Emergency Medicine. doi.org/10.1016/j.ajem.2019.12.012.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breast cancer mortality plummets by 44%, but alarming racial gaps persist